Phase 1 11 trials
Phase 1
NCT01204476 Oct 2010 → Jul 2014 PPoma , cutaneous neuroendocrine carcinoma , gastrin-producing neuroendocrine tumor , glucagonoma +5 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01182883 Jul 2010 → Apr 2012 brainstem neoplasm , glioma , pineal body neoplasm National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 1
NCT01061749 Nov 2009 → Apr 2013 neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01007032 Nov 2009 → Dec 2012 neoplasm Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT01008566 Aug 2009 → May 2016 adult hepatocellular carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00880282 Apr 2009 → Oct 2012 childhood malignant neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00720174 Jun 2008 → Jan 2013 adult epithelioid sarcoma , adult extraskeletal osteosarcoma , adult fibrosarcoma , adult liposarcoma +17 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00678769 May 2008 → Jun 2013 cancer National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00609141 Jan 2008 → Sep 2009 Ewing sarcoma/peripheral primitive neuroectodermal tumor , childhood malignant neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00785941 Apr 2006 → Oct 2007 cancer Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT00785538 Oct 2005 → Jan 2011 cancer Eli Lilly and Company
Completed
No outcome recorded
Show 1 more trial Phase 1/2 4 trials
Phase 1/2
NCT01026623 Oct 2009 → Feb 2013 hormone-resistant prostate carcinoma , prostate adenocarcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00699491 Oct 2008 → Sep 2013 male breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00778167 Oct 2008 → May 2012 non-small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1/2
NCT00617708 Mar 2008 → Sep 2012 pancreas disorder National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2 28 trials · 7 missed
Phase 2
NCT01614795 Jun 2012 → Apr 2014 Ewing sarcoma/peripheral primitive neuroectodermal tumor , alveolar soft part sarcoma , childhood epithelioid sarcoma , gliosarcoma +7 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00957853 Oct 2011 → Aug 2018 head and neck squamous cell carcinoma M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 2
NCT01413191 Aug 2011 → Mar 2013 iris melanoma , medium/large size posterior uveal melanoma , small size posterior uveal melanoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01263782 May 2011 → Aug 2017 lung cancer M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 2
NCT01232452 Apr 2011 → Jan 2013 non-small cell lung carcinoma Eli Lilly and Company
Completed
Missed primary
Phase 2
NCT01120236 Dec 2010 → Jun 2015 prostate adenocarcinoma National Cancer Institute (NCI)
Completed
Missed primary
Phase 2
NCT01142388 Sep 2010 → Jul 2014 overdue esophageal adenocarcinoma , esophageal squamous cell carcinoma , gastroesophageal junction adenocarcinoma National Cancer Institute (NCI)
Active not recruiting
Missed primary
Phase 2
NCT01160458 Jun 2010 → Aug 2016 malignant peritoneal mesothelioma , malignant pleural mesothelioma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00955305 Mar 2010 → Jan 2016 lung adenocarcinoma , lung large cell carcinoma National Cancer Institute (NCI)
Terminated
Missed primary
Stop: Enrollment
Phase 2
NCT01055314 Jan 2010 → Jun 2016 alveolar rhabdomyosarcoma , embryonal rhabdomyosarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT01016015 Nov 2009 → Jul 2014 osteosarcoma , soft tissue sarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00986674 Sep 2009 → Aug 2013 non-small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00965250 Aug 2009 → Mar 2012 thymic carcinoma , thymic neuroendocrine tumor , thymoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00887159 Jul 2009 → Nov 2016 small cell lung carcinoma National Cancer Institute (NCI)
Completed
Missed primary
Phase 2
NCT00845039 May 2009 → Feb 2011 colon carcinoma , rectal cancer Eli Lilly and Company
Terminated
No outcome recorded
Stop: Business
Phase 2
NCT00870870 Mar 2009 → Apr 2012 non-small cell lung carcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT00781911 Feb 2009 → Jul 2011 carcinoma , neuroendocrine neoplasm Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT00831844 Jan 2009 → Apr 2013 Ewing sarcoma/peripheral primitive neuroectodermal tumor , adrenal cortex carcinoma , childhood kidney neoplasm , hepatoblastoma +5 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00778817 Dec 2008 → May 2012 adrenal cortex carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00769795 Oct 2008 → Aug 2011 prostate cancer University of Washington
Completed
No outcome recorded
Phase 2
NCT00683475 Aug 2008 → Sep 2011 prostate cancer Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT00728949 Aug 2008 → Mar 2012 breast cancer Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT00684983 Jul 2008 → Jan 2014 HER2 positive breast carcinoma National Cancer Institute (NCI)
Completed
Missed primary
Phase 2
NCT00668148 Jul 2008 → Oct 2010 Ewing sarcoma/peripheral primitive neuroectodermal tumor , leiomyosarcoma , liposarcoma , rhabdomyosarcoma +1 Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT00639509 Mar 2008 → Feb 2011 adult hepatocellular carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00617734 Mar 2008 → Feb 2012 head and neck cancer Eli Lilly and Company
Completed
Missed primary
Phase 2
NCT00520481 Aug 2007 → Jan 2012 prostate adenocarcinoma Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT00503685 Jun 2007 → Mar 2009 colorectal cancer Eli Lilly and Company
Completed
No outcome recorded
Show 18 more trials Comparator or background therapy 1 trial
Phase 2
NCT00906373 Comparator May 2009 → Oct 2012 hepatocellular carcinoma Eli Lilly and Company
Completed
No outcome recorded